Publication date: Apr 15, 2025
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder with 4-repeat (R) tau protein deposition. The substantia nigra (SN) and midbrain tegmentum nuclei (MBT) are consistently affected. Lymphocyte infiltrates are scarce in the brain of neurodegenerative diseases, although a few reports have described this feature in brains with the α-synucleinopathy, Parkinson’s disease (PD). To evaluate cytotoxic T-cell response, serial sections spanning 120 microns of the SN were consecutively immunostained for phosphorylated tau (AT8) or α-synuclein, cytotoxic T-cell marker, and microglia marker HLA-DR. Sections were analyzed with stereology software in 9 patients with PSP, 10 with PD, and 6 healthy controls. We semiquantitatively scored CD8-positive cells in further brain regions. CD8 lymphocyte cell counts, and microglial activation were increased in the SN of PSP compared to PD and controls. T-cell/neuron contact was observed in PSP. In multivariate models, CD8 counts were not predicted by disease duration, younger age at death, and by the amount of p-tau pathology. SN and midbrain tegmentum showed more CD8 cells than the cortex. The presence of more prominent nigral cytotoxic T-cell response in PSP than in PD supports the notion that the common p-tau neuropathology in PSP might have potential relationships with autoimmune mechanisms.
Concepts | Keywords |
---|---|
Lymphocyte | inflammation |
Neurodegenerative | neuropathology |
Nigra | progressive supranuclear palsy |
Parkinson | T-lymphocyte |
Relationships | tau |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | progressive supranuclear palsy |
disease | MESH | neurodegenerative disorder |
pathway | REACTOME | Neurodegenerative Diseases |
disease | MESH | synucleinopathy |
disease | MESH | Parkinson’s disease |
disease | MESH | death |
disease | MESH | inflammation |